New Xylazine Research Conducted by Cooper Physicians
Congratulations to Joseph D'Orazio, MD, FAAEM, FACMT, FASAM, FCPP, Addiction Medicine Specialist at Cooper, and Rachel Haroz, MD, FAACT, Medical Director of the Cooper Center for Healing and Division Head of Toxicology…
Read the story